Boehringer Ingelheim Canada Ltd, Research and Development, 2100 Cunard Street, Laval, Que, Canada.
Bioorg Med Chem Lett. 2011 Jan 1;21(1):398-404. doi: 10.1016/j.bmcl.2010.10.131. Epub 2010 Oct 31.
The discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly is described. Synthesis of analogs of the 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione hit established structure-activity relationships. Replacement of the enamine functionality of the hit series with either an imidazole or a pyrazole ring led to compounds that inhibited both capsid assembly and reverse transcriptase. Optimization of the bicyclic benzodiazepine scaffold to include a 3-phenyl substituent led to lead compound 48, a pure capsid assembly inhibitor with improved antiviral activity.
描述了一系列抑制 HIV-1 衣壳组装的 1,5-二氢苯并[b][1,4]二氮杂*-2,4-二酮抑制剂的发现。类似物的合成建立了 1,5-二氢苯并[b][1,4]二氮杂*-2,4-二酮的命中结构-活性关系。用咪唑或吡唑环取代命中系列的烯胺官能团,得到了既抑制衣壳组装又抑制逆转录酶的化合物。对包含 3-苯基取代基的双环苯并二氮杂*骨架进行优化,得到先导化合物 48,这是一种纯衣壳组装抑制剂,具有改善的抗病毒活性。